AmyMartinScurlockMD

Professor, Pediatrics, University of Arkansas COM

Dr. Scurlock is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Arkansas Children's Hospital
1 Children's Way
Little Rock, AR 72202
Phone+1 501-263-2621

Duke University HospitalFellowship, Allergy and Immunology, 2002 - 2004
University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Pediatrics, 1998 - 2002
University of Arkansas For Medical Sciences College of MedicineClass of 1998

Chlamydia Trachomatis Persistence in the Female Gastrointestinal Tract Start of enrollment: 2006 Feb 01
Withdrawn
Immunopathogenesis of Chlamydia Start of enrollment: 2008 Jan 01
Completed
Allergic Disease Onset Prevention Study Start of enrollment: 2021 Sep 01
Active, not recruiting
Phase 1, Phase 2
Roles: Contact

PubMed

79 citations
Toll-Like Receptor 2 Activation by Chlamydia trachomatis Is Plasmid Dependent, and Plasmid-Responsive Chromosomal Loci Are Coordinately Regulated in Response to Glucos...
Catherine M. O'Connell, Yasser M. AbdelRahman, Erin R. Green, Hillary K. Darville, Kazima Saira
Infection and Immunity. 2011-03-01
20 citations
Impact of food allergy on food insecurity and health literacy in a tertiary care pediatric allergy population.
Meredith A. Dilley, Mallikarjuna Rettiganti, Lynn Christie, Erin O'Brien, Megan Patterson
Pediatric Allergy and Immunology. 2019-05-01
166 citations
Plasmid-Deficient Chlamydia muridarum Fail to Induce Immune Pathology and Protect against Oviduct Disease
Catherine M. O'Connell, Robin R. Ingalls, Charles W. Andrews, Amy M. Scurlock, Toni Darville
Journal of Immunology. 2007-09-15

NIH Clinical Trial Conducted in Part at Arkansas Children’s Produces First FDA-Approved Treatment for Multiple Severe Food AllergiesFebruary 29th, 2024
DBV Technologies to Present Data from Epicutaneous Immunotherapy at EAACI 2019June 1st, 2019
Study Led by Johns Hopkins Medicine Finds Injectable Drug Used to Treat Asthma and Other Allergic Conditions May Limit Reactions in People with Multiple Food AllergiesFebruary 26th, 2024
Join now to see all